Impact of sinus rhythm restoration and maintenance on left ventricular function and exercise tolerance in patients with persistent atrial fibrillation;Wpływ przywrócenia i utrzymania rytmu zatokowego na funkcjȩ lewej komory i tolerancjȩ wysiłku u chorych z przetrwałym migotaniem przedsionków

Kardiologia Polska

Volumn 63, Issue 1, 2005, Pages 36-49

  Kosior, Dariusz A ^a,d   Stawicki, Sławomir ^a,d   Wozakowska Kapłon, Beata ^b,e   Szulc, Marcin ^a   Opolski, Grzegorz ^a,d   Rabczenko, Daniel ^c,f   Musiał, Włodzimierz ^g  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Department of Cardiology ^*  (Poland)

^c NATIONAL INSTITUTE OF HYGIENE   (Poland)

^d WARSZAWSKI UNIWERSYTET MEDYCZNY   (Poland)

^e Swietokrzyskie Centrum Kardiologii Poland   (Poland)

^f Instytut Higieny   (Poland)

^g MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Electrical cardioversion; Heart failure; Persistent atrial fibrillation

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; VERAPAMIL;

ADULT; AGED; ARTICLE; CARDIOVERSION; DISEASE ACTIVITY; DISEASE SEVERITY; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART WORK; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PARAMETER; SINUS RHYTHM; SYMPTOM; TREATMENT OUTCOME; WORKLOAD;

EID: 23844446669     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Van Gelder I.C., Crijns H.J.G.M., Blanskma M.C. et al.: Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am. J. Cardiol. 1993, 72, 560-566.
2. Atwood J.E., Myers J., Sulliwan M. et al.: The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation. Am. Heart J. 1989, 118, 913-917.
3. Van Gelder J., Hagens V.E., Bosker H.A. et al.: A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N. Engl. J. Med. 2002, 347, 1834-1840.
4. Carlsson J., Miketic S., Windeler J. et al.: Randomized trial of rate-control versus rhythm control in persistent atrial fibrillation. The Strategies of Treatment of Atrial Fibrillation (STAF) study. J. Am. Coll. Cardiol. 2003, 41, 1690-1696.
5. A comparison of rate control and rhythm control in patients with atrial fibrillation. The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Investigators. N. Engl. J. Med. 2002, 347, 1825-1833.
6. Hohnloser S.H., Kuck K.H., Lilienthal J. et al.: Rhythm or rate control in atrial fibrillation - Pharmacological Intervention In Atrial Fibrillation (PIAF): a randomized trial. Lancet 2000, 356, 1789-1794.
7. Opolski G., Torbicki A., Kosior D. et al.: Rate Control vs Rhythm Control in Patients With Nonvalvular Persistent Atrial Fibrillation: The Results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest 2004, 126, 476-486.
8. Opolski G., Torbicki A., Kosior D. et al.: Przetrwałe migotanie przedsionków - porównanie dwóch strategii leczenia: przywrócenie rytmu zatokowego versus kontrola rytmu serca. Wyniki polskiego badania HOT CAFE. Kardiol. Pol. 2003, 59, 8-16.
9. Laupacis A., Albers G., Dalen J. et al.: Antithrombotic therapy in atrial fibrillation. Chest 1995, 108, 352-359.
10. Lipkin D.P., Frenneaux M., Stewart R. et al.: Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhtyhm. Br. Heart J. 1998, 15, 1368-1372.
11. Shapiro E.P., Effron M.B., Lima S. et al.: Transient atrial dysfunction after cardioversion of chronic atrial fibrillation to sinus rhtyhm. Am. J. Cardiol. 1988, 62, 1202-1207.
12. Gosselink A.T.M., Smit A.J., Crijns H.J.G.M. et al.: Alternation of peripheral vasodilatatory reserve capacity after cardioversion of atrial fibrillation. Eur. Heart J. 1996, 17, 926-930.
13. Gosselink A.T.M., Crijns H.J.G.M., Hamer H.P.M. et al.: Changes of left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease. J. Am. Coll. Cardiol. 1993, 22, 1666-1672.
14. Gosselink A.T.M., Crijns H.J.G.M., Van Der Berg M.P. et al.: Functional capacity before and after cardioversion of atrial fibrillation: a controlled study. Br. Heart J. 1994, 72, 161-166.
15. Ostermeier R.H., Lampert S., Dalla Vecchia L. et al.: The effect of atrial fibrillation and the ventricular rate control on exercise capacity. Clin. Cardiol. 1997, 20, 23-27.
16. Ueshima K., Myers J., Morris C.K. et al.: The effect of cardioversion on exercise capacity in patients with atrial fibrillation. Am. Heart J. 1993, 126, 1021-1024.